Roche Partners With UCB On Anti-Tau Alzheimer’s Drug

 
• By Joseph Haas
  
Alzheimers_677117191_Atthapon-Raksthaput_1200.jpg
Roche takes another shot in Alzheimer's by licensing UCB anti-tau candidate
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business